![Michael N. Avallone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Michael N. Avallone.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 8 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Michael N. Avallone a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
ALERE INC | Medical Specialties | Chief Executive Officer | |
Point32health Services, Inc.
![]() Point32health Services, Inc. Life/Health InsuranceFinance Tufts Associated Health Plans, Inc. provides healthcare plans. It offers health care coverage options to individuals and employer groups. The firm also offers choice tiered network option plan and Steward Community Choice, a community-based plan, developed in conjunction with Steward Health Care System. The company was founded by Morton A. Madoff in 1979 and is headquartered in Watertown, MA. | Life/Health Insurance | Chairman | |
VIRTUS DIVERSIFIED INCOME & CONVERTIBLE FUND | Investment Trusts/Mutual Funds | Director/Board Member | |
VIRTUS CONVERTIBLE & INCOME FUND | Investment Trusts/Mutual Funds | Chairman | |
VIRTUS CONVERTIBLE & INCOME FUND II | Investment Trusts/Mutual Funds | Chairman | |
Sun Life Financial (U.S.) Reinsurance Co. | Director of Finance/CFO | ||
ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member | |
Virtus Investment Trust | Investment Trusts/Mutual Funds | Chairman | |
University of Wisconsin | College/University | Undergraduate Degree | |
VIRTUS DIVIDEND, INTEREST & PREMIUM STRATEGY FUND | Investment Trusts/Mutual Funds | Chairman | |
CardioKine, Inc.
![]() CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Director/Board Member | |
Tom's of Maine, Inc.
![]() Tom's of Maine, Inc. Household/Personal CareConsumer Non-Durables Tom's of Maine, Inc. manufactures and markets personal care products. It provides natural products for hair, teeth, skin and cold care. It also manufactures antiperspirants, soaps, shampoos and shaving cream made from natural ingredients. The company was founded in 1970 by Tom Chappell and Kate Chappell and is headquartered in Kennebunk, ME. | Household/Personal Care | Director of Finance/CFO | |
NitroMed, Inc.
![]() NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member | |
Hopewell Therapeutics, Inc.
![]() Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer | |
ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
PLC Medical Systems, Inc.
![]() PLC Medical Systems, Inc. Medical SpecialtiesHealth Technology PLC Medical Systems, Inc. provides medical devices. It offers technologies for cardiac and vascular markets. The company was founded on August 23, 1982 and is headquartered in Milford, MA. | Medical Specialties | Director/Board Member | |
RADIUS HEALTH, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
VIRTUS EQUITY & CONVERTIBLE INCOME FUND | Investment Trusts/Mutual Funds | Director/Board Member | |
VIRTUS CONVERTIBLE & INCOME 2024 TARGET TERM FUND | Investment Trusts/Mutual Funds | Chairman | |
ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
UCLA Anderson School of Management | College/University | Masters Business Admin | |
Ithaca College | College/University | Undergraduate Degree | |
REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing | |
American Association of Kidney Patients, Inc. | Director/Board Member | ||
OPKO HEALTH, INC. | Medical/Nursing Services | Sales & Marketing | |
CODA Biotherapeutics, Inc.
![]() CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Chief Executive Officer | |
Amgen KK
![]() Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Thousand Oaks Corp.
![]() Thousand Oaks Corp. Wholesale DistributorsDistribution Services Thousand Oaks Corp. is an American company that wholesales sporting goods. | Wholesale Distributors | Corporate Officer/Principal | |
ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
Yale University | College/University | Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
University of California, Davis | College/University | Graduate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ren Pharmaceuticals, Inc.
![]() Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Chairman | |
NCH Healthcare System, Inc.
![]() NCH Healthcare System, Inc. Electronic Equipment/InstrumentsElectronic Technology NCH Healthcare System, Inc. provides healthcare systems and services. It offers diagnostics, rehabilitation, home care, nutrition, and ancillary services. The company was founded in 1953 and is headquartered in Naple, FL. | Electronic Equipment/Instruments | Director/Board Member | |
VIRTUS ARTIFICIAL INTELLIGENCE & TECHNOLOGY OPPORTUNITIES FUND | Investment Trusts/Mutual Funds | Director/Board Member | |
Albireo AB
![]() Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 49 |
Japón | 2 |
Suecia | 2 |
Sectorial
Health Technology | 26 |
Miscellaneous | 9 |
Consumer Services | 8 |
Finance | 4 |
Consumer Non-Durables | 2 |
Operativa
Director/Board Member | 53 |
Chairman | 23 |
Independent Dir/Board Member | 19 |
Chief Executive Officer | 14 |
President | 13 |
Las relaciones más conectadas
Insiders | |
---|---|
Davey Scoon | 24 |
Brian Pereira | 23 |
Ron Zwanziger | 16 |
Michael Narachi | 14 |
Louis Brenner | 12 |
Joseph Farmer | 10 |
E. Scott Toner | 7 |
Timothy G. Healey | 6 |
- Bolsa de valores
- Insiders
- Michael N. Avallone
- Conexiones Empresas